SEC FORM 4
$6,768.90
4D Molecular Therapeutics, Inc. (FDMT)
Acquisition (code M) of 1,635 shares at $4.14 per share.
Reporting Person Bizily Scott · Officer Title Chief Legal Officer · Transaction Code M
Traded Aug 13, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001193125-26-354313 · filed 2026-08-17 · View filing →